Matthew T. Wiley

Insider Reports History

Location
Rehovot, Israel
Signature
/s/Mark Sullivan, Attorney-in-Fact for Matthew T. Wiley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew T. Wiley:

Company Role Class Num Shares Value Price $ Report Date Ownership
VYNE Therapeutics Inc. Chief Commercial Officer Common Stock 109,246 $249,081 $2.28 30 Jun 2021 Direct
BioXcel Therapeutics, Inc. Chief Commercial Officer Common Stock 19,011 $10,456 $0.5500 03 Oct 2024 Direct
BioXcel Therapeutics, Inc. Chief Commercial Officer Restricted Stock Units 7,500 $9,600 $1.28 15 Sep 2024 Direct
Mind Medicine (MindMed) Inc. Chief Commercial Officer Stock Option (Right to Buy) 350,000 17 Mar 2025 Direct
BioXcel Therapeutics, Inc. Chief Commercial Officer Stock Option (right to buy) 1,875 22 Jul 2024 Direct

Insider Reports Filed by Matthew T. Wiley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNMD Mind Medicine (MindMed) Inc. 17 Mar 2025 1 $0 4 Chief Commercial Officer 18 Mar 2025, 16:45
MNMD Mind Medicine (MindMed) Inc. 17 Mar 2025 0 $0 3 Chief Commercial Officer 18 Mar 2025, 16:30
BTAI BioXcel Therapeutics, Inc. 17 Sep 2024 2 -$3,450 4 Chief Commercial Officer 03 Oct 2024, 21:55
BTAI BioXcel Therapeutics, Inc. 15 Sep 2024 3 -$149 4 Chief Commercial Officer 17 Sep 2024, 19:18
BTAI BioXcel Therapeutics, Inc. 22 Jul 2024 1 $0 4 Former Chief Commercial Officer 01 Apr 2025, 18:06
BTAI BioXcel Therapeutics, Inc. 15 Jun 2024 1 $0 4/A Chief Commercial Officer 17 Sep 2024, 19:17
BTAI BioXcel Therapeutics, Inc. 15 Mar 2024 3 -$2,656 4 CHIEF COMMERCIAL OFFICER 08 Apr 2024, 19:31
BTAI BioXcel Therapeutics, Inc. 15 Mar 2023 2 $0 4 CHIEF COMMERCIAL OFFICER 16 Mar 2023, 17:58
BTAI BioXcel Therapeutics, Inc. 17 Jan 2022 1 $0 4 CHIEF COMMERCIAL OFFICER 19 Jan 2022, 15:19
BTAI BioXcel Therapeutics, Inc. 17 Jan 2022 0 $0 3 CHIEF COMMERCIAL OFFICER 19 Jan 2022, 15:15
VYNE VYNE Therapeutics Inc. 30 Jun 2021 1 -$18,080 4 Chief Commercial Officer 02 Jul 2021, 16:36